Atrial Fibrillation Modifies the Relationship Between Beta Blocker Dose and Physical Capacity After Myocardial Infarction
Clinics and Practice · 28.03.2026 · 16 (4) · 67
DOI: 10.3390/clinpract16040067 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinics and Practice, online erschienen am 28.03.2026. Verfasst von Paulina Rabiej-Krzys und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Cardinal Wyszynski Hospital in Lublin, al. Krasnicka 100, 20-718 Lublin, Poland. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science Centre, National Science Center Poland—NCN MINIATURA.
Abstract (Originalsprache)
Background
Atrial fibrillation (AF) is a common arrythmia in post-myocardial infarction (MI) cardiac rehabilitation (CR) cohorts, and beta-adrenergic signaling remodeling and rate-control pharmacotherapy may influence functional capacity.
Methods
We retrospectively studied 117 consecutive male post-MI patients referred to outpatient CR. Functional capacity was assessed with a 6 min walk test (6MWT). AF was identified from clinical records, and beta-blocker exposure was unified as carvedilol-equivalent daily dose.
Results
Beta-blockers were used in 94.1% of patients and AF was present in 10.3%. Patients with AF were older (72.7 ± 6.6 vs 58.1 ± 9.3 years) and walked shorter distances (430.0 [375.0–497.5] vs. 540.0 [480.0–570.0] m). In the prespecified interaction model, age remained independently associated with lower 6MWT (−4.29 m/year; p < 0.001), AF was associated with lower 6MWT (−137.21 m; p = 0.01), and the beta-blocker dose × AF interaction was positive (+6.78; p = 0.02; R2 = 0.44). Importantly, the beta-blocker dose was not associated with 6MWT in patients without AF, whereas a positive association was observed in AF (B = 7.55, p = 0.04).
Conclusions
In this exploratory analysis, AF identified a subgroup with markedly reduced functional capacity in early post-MI CR, supporting the potential of phenotype-informed assessment. Additionally, the association between beta-blocker dose and 6MWT distance differed by rhythm status. These preliminary findings require confirmation in larger prospective cohorts.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology, Cardinal Wyszynski Hospital in Lublin, al. Krasnicka 100, 20-718 Lublin, Poland.
- Department of Clinical Dietetics, Medical University of Lublin, ul. Chodzki 7, 20-093 Lublin, Poland.
- Cardiac Rehabilitation Center, Cardinal Wyszynski Hospital in Lublin, al. Krasnicka 100, 20-718 Lublin, Poland.
- Cardiac Rehabilitation Unit, Rehabilitation Clinic 'Villa delle Magnolie', 81020 Castel Morrone, Caserta, Italy.
ORCID-Profile: Karolina Szczygiel, Francesco Perone, Joanna Popiolek-Kalisz
Förderung
- National Science Centre
- National Science Center Poland—NCN MINIATURA
Zitieren
APA
Rabiej-Krzys, P., Szczygiel, K., Lenard, R., Perone, F., & Popiolek-Kalisz, J. (2026). Atrial Fibrillation Modifies the Relationship Between Beta Blocker Dose and Physical Capacity After Myocardial Infarction. Clinics and Practice, 16(4), 67. https://doi.org/10.3390/clinpract16040067
Vancouver
Rabiej-Krzys P, Szczygiel K, Lenard R, Perone F, Popiolek-Kalisz J. Atrial Fibrillation Modifies the Relationship Between Beta Blocker Dose and Physical Capacity After Myocardial Infarction. Clinics and Practice. 2026;16(4):67. doi:10.3390/clinpract16040067
BibTeX
@article{RabiejKrzys2026,
author = {Rabiej-Krzys, Paulina and Szczygiel, Karolina and Lenard, Rafal and Perone, Francesco and Popiolek-Kalisz, Joanna},
title = {Atrial Fibrillation Modifies the Relationship Between Beta Blocker Dose and Physical Capacity After Myocardial Infarction},
journal = {Clinics and Practice},
year = {2026},
volume = {16},
number = {4},
pages = {67},
doi = {10.3390/clinpract16040067}
}
EUVIMED